Workflow
募集资金专户管理
icon
Search documents
奥精医疗: 奥精医疗:关于注销募集资金专户的公告
Zheng Quan Zhi Xing· 2025-07-23 10:17
Fundraising Overview - The company raised a total of RMB 547,666,677.62 through the issuance of 33,333,334 shares at a price of RMB 16.43 per share, with a net amount of RMB 500,816,913.05 after deducting issuance costs [1][2] - The funds were verified by an accounting firm and were deposited into a dedicated bank account [1] Fund Management - The company and its subsidiaries have opened dedicated fundraising accounts at various banks to ensure proper management and usage of the raised funds [2] - Agreements have been signed with banks to regulate the management of these funds [2][3] Account Closure - The company has closed a specific fundraising account at Industrial Bank Co., Ltd. due to adjustments in the project implementation [4] - The closure of this account has led to the termination of the corresponding four-party supervision agreement [4]
颀中科技: 合肥颀中科技股份有限公司关于部分募集资金专户销户完成的公告
Zheng Quan Zhi Xing· 2025-07-20 08:22
Core Points - The company has completed the cancellation of part of its fundraising special account [1][4] - The net amount raised from the public offering of shares was RMB 2,232.6262 million [1] - The company established a special account for fundraising in accordance with relevant regulations and signed a tripartite supervision agreement [2][3] Fundraising Overview - The company was approved by the China Securities Regulatory Commission to publicly issue ordinary shares, raising a net amount of RMB 2,232.6262 million [1] - The funds have been verified by Tianzhi International Accounting Firm [1] - The company has implemented a special account storage system for the raised funds to ensure proper management and usage [2][3] Fund Management - The company has developed a management method for fundraising, detailing the storage, usage, and management of the funds [2] - The company has signed tripartite supervision agreements with several banks to ensure compliance with the regulations [3] - The management of the funds is strictly in accordance with the established agreements, with no significant differences from the standard agreements provided by the Shanghai Stock Exchange [3] Account Cancellation - The company held a board meeting on June 18, 2025, to approve a share repurchase plan using excess funds and has completed the cancellation of the special account at Shanghai Pudong Development Bank [4] - The tripartite supervision agreement related to the fundraising special account has been terminated following the account cancellation [4]
迪哲(江苏)医药股份有限公司关于注销部分募集资金专项账户的公告
Core Points - The company has completed the cancellation of certain special accounts for raised funds from its initial public offering and private placement [1][5][6] Fundraising Overview - The company raised a total of RMB 2,103,205,258.00 from its initial public offering, with a net amount of RMB 1,986,567,781.57 after deducting issuance costs [1] - The company also raised RMB 1,795,886,744.00 from a private placement, resulting in a net amount of RMB 1,773,446,130.53 after deducting issuance costs of RMB 22,440,613.47 [2] Fund Management - The company has established a management method for the use of raised funds, ensuring compliance with relevant laws and regulations, and has implemented special account management for the funds [3] Account Cancellation Details - The company has canceled several fundraising special accounts due to minimal remaining balances, transferring the remaining funds to other operational accounts [5] - The cancellation of these accounts has been completed, and the corresponding storage supervision agreements have been terminated [6]